Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Permeability Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma

NCT01499823 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT01499823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01499823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Permeability Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma
Lead sponsor
Seoul National University Hospital
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2011
Completion date
December 31, 2013
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high grade glioma